Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma

Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma

Background: Carcinoma ex pleomorphic adenoma (CXPA) is a rare histologic subtype of lacrimal gland and submandibular gland cancer. Currently, there is no standard treatment for metastatic CXPA, although some case reports have explored the role of targeted agents in chemotherapy. A few histopathologi...

Full description

Bibliographic Details
Main Authors: Yohei Arihara, Kazuyuki Murase, Kohichi Takada, Naotaka Hayasaka, Shogo Miura, Koji Miyanishi, Masayoshi Kobune, Makoto Kurose, Yukinori Akiyama, Shintaro Sugita, Junji Kato
Format: Article
Language:English
Published: Karger Publishers 2018-12-01
Series:Case Reports in Oncology
Subjects:
HER2
Carcinoma ex Pleomorphic Adenoma
CXPA
Trastuzumab
Nab-paclitaxel
Online Access:https://www.karger.com/Article/FullText/495344

Internet

https://www.karger.com/Article/FullText/495344

Similar Items